// App-Quantinova.ai

: Effectiveness and Tolerability of Perampanel in Epilepsy Patients Treated in Routine Clinical Practice: a Global Pooled Analysis Study

Researchers

Presenter

  • Wendyl DSouza

Principal Investigators

  • Eugen Trinka

  • Tony Wu

  • Imad Najm

  • Manoj Malhotra

  • Leock Y Ngo

  • Rob McMurray

  • Vicente Villanueva

Medical Centers

  • Department of Medicine St Vincent's Hospital, University of Melbourne, Fitzroy, Australia

  • Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Salzburg, Austria

  • Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan

  • Cleveland Clinic Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA

  • Eisai Inc, Woodcliff Lake, New Jersey, USA

  • European Knowledge Centre, Eisai Europe Ltd, Hatfield, Hertfordshire, UK

  • Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Locations

  • Australia

  • Austria

  • Taiwan

  • United States

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Epilepsy

Biomarkers

  • N/A

Drug/Treatment

  • Perampanel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved